Evaluation of operational chronic infection endpoints for HCV vaccine trialsKANG, Minhee; NICOLAY, Uwe.Contemporary clinical trials. 2008, Vol 29, Num 5, pp 671-678, issn 1551-7144, 8 p.Article

Prevention of Suture hole bleeding using fibrin sealant : Benefits of factor XIIIDICKNEITE, Gerhard; METZNER, Hubert; NICOLAY, Uwe et al.The Journal of surgical research. 2000, Vol 93, Num 2, pp 201-205, issn 0022-4804Article

Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine : A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate®, stored at room temperature for 6 monthsSCHÖNDORF, Ines; BANZHOFF, Angelika; NICOLAY, Uwe et al.Vaccine. 2007, Vol 25, Num 7, pp 1175-1182, issn 0264-410X, 8 p.Article

Comparison of the safety and immunogenicity of an MF59^®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjectsFREY, Sharon E; APLASCA-DE LOS REYES, Mari Rose; REYNALES, Humberto et al.Vaccine. 2014, Vol 32, Num 39, pp 5027-5034, issn 0264-410X, 8 p.Article

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysisBLACK, Steven; DELLA CIOPPA, Giovanni; MALFROOT, Anne et al.Vaccine. 2010, Vol 28, Num 45, pp 7331-7336, issn 0264-410X, 6 p.Article

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety databasePELLEGRINI, Michele; NICOLAY, Uwe; LINDERT, Kelly et al.Vaccine. 2009, Vol 27, Num 49, pp 6959-6965, issn 0264-410X, 7 p.Article

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in ChildrenBLACK, Steven; NICOLAY, Uwe; VESIKARI, Timo et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 12, pp 1081-1085, issn 0891-3668, 5 p.Article

The importance of factor XIII as a component of fibrin sealantsDICKNEITE, Gerhard; METZNER, Hubert J; KROEZ, Monika et al.The Journal of surgical research. 2002, Vol 107, Num 2, pp 186-195, issn 0022-4804, 10 p.Article

Trivalent and quadrivalent MF59^®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding studyDELLA CIOPPA, Giovanni; VESIKARI, Timo; SOKAL, Etienne et al.Vaccine. 2011, Vol 29, Num 47, pp 8696-8704, issn 0264-410X, 9 p.Article

Explorations of clinical trials and pharmacovigilance databases of MF59^®-adjuvanted influenza vaccines for associated cases of narcolepsyTSAI, Theodore F; CRUCITTI, Antonio; NACCI, Pantaleo et al.Scandinavian journal of infectious diseases. 2011, Vol 43, Num 9, pp 702-706, issn 0036-5548, 5 p.Article

From clinical evidence to everyday practice: implementing findings from a cost-effectiveness analysis for endoscopic injection therapy for upper-gastrointestinal bleedingSITTER, Helmut; LORENZ, Wilfried; NICOLAY, Uwe et al.European journal of gastroenterology & hepatology. 2003, Vol 15, Num 3, pp 295-304, issn 0954-691X, 10 p.Article

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeGARDULF, Ann; NICOLAY, Uwe; KUS, Jan et al.Journal of allergy and clinical immunology. 2004, Vol 114, Num 4, pp 936-942, issn 0091-6749, 7 p.Article

Purified Chick Embryo Cell Culture Rabies Vaccine : interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized personsBRIGGS, Deborah J; DREESEN, David W; NICOLAY, Uwe et al.Vaccine. 2000, Vol 19, Num 9-10, pp 1055-1060, issn 0264-410XArticle